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Abstract
This study aimed to examine the relationship of adherence with blood pressure (BP) 
control and its associated factors in hypertensive patients. This cross‐ sectional na‐
tionwide BP screening study was conducted in Malaysia from May to October 2018. 
Participants with self‐ declared hypertension completed the Hill‐ Bone Compliance to 
High Blood Pressure Therapy Scale (Hill‐ Bone CHBPTS) which assesses three impor‐
tant domains of patient behavior to hypertension management namely medication 
taking, appointment keeping and reduced salt intake. Lower scores indicate better 
compliance while higher scores indicate otherwise. Participant's body mass index and 
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1  |  INTRODUC TION
Hypertension affects a quarter of the world's population with prev‐
alence ranging from 26.4% to 31.1% worldwide and is expected to 
increase over the years.1,2 Hypertension is the major contributor of 
mortality and continues to contribute significantly to the increase 
of cardiovascular diseases, renal failure, and mortality.1,3,4 Around 
61.3% to 77.2% of hypertensive patients from developed countries 
receive treatment in contrast to 18%‐ 41.1% in several low‐ and 
middle‐ income countries in Asia.2,5,6 Even in several countries in Asia 
where treatment rates are high (69.7%‐ 81%), control of blood pres‐
sure (BP) is only achieved in less than 50%, for example in Malaysia, 
83.2% of patients with hypertension received treatment but control 
of hypertension is only 37.4% while in many other low‐ and middle‐ 
income countries in Asia, the control rates are even lower with sev‐
eral below 20%.6,7
Although guidelines on hypertension emphasize the need to 
address treatment adherence throughout the world and also in 
Malaysia, just over half adhere to their medication.8‐ 11 Poor BP con‐
trol remains a global concern. Uncontrolled hypertension leads to 
multiple complications which increases the burden to the individual 
and healthcare system.12
Many factors that contribute to poor BP control have been 
identified, the commonest being poor patient adherence to med‐
ication.13 Besides medication adherence, adherence to lifestyle 
modification, reduction of salt intake, follow‐ up appointment, and 
medication refilling are also important contributors to poor BP 
control.13,14 Understanding the contributing factors is important in 
improving overall adherence to prevent target organ damage such 
as strokes and myocardial infarctions; thus, more targeted interven‐
tions may be implemented to improve the control of hypertension.15 
To date, there are limited studies that examine the level of adherence 
beyond medication taking. However, as reiterated earlier, it is im‐
portant to study other factors that contribute to better control of 
hypertension. Hence, this nationwide study aimed to examine the 
level of adherence to hypertension management among patients 
with hypertension, using the Hill‐ Bone Compliance to High Blood 
Pressure Therapy Scale (Hill‐ Bone CHBPTS) which has 3 domains 
of medication adherence, salt reduction, and appointment keeping.
2  |  MATERIAL AND METHODS
2.1  |  Study design and setting
This cross‐ sectional study was conducted throughout Malaysia 
during a worldwide BP screening campaign in conjunction with 
World Hypertension Day 2018. The study was conducted over 
5 months from May 1, 2018, to October 31, 2018. The screening 
program was carried out at various centers including health clinics, 
hospitals, universities, community centers, shopping malls, family 
day events, and health runs in Peninsular Malaysia and 2 other 
sites in East Malaysia. Twenty‐ five investigators from the 22 cent‐
ers were briefed on the use of a standardized protocol.16,17 Ethics 
approval was granted by the National Medical Research Register 
(NMRR‐ 18‐ 876‐ 40691) and University of Malaya Medical Centre 
(MREC ID NO:2018320‐ 6146).
2.2  |  Sample size calculation
As this is a public screening programme, the sample size was not 
calculated. All adults aged 18 years and above were eligible for the 
study.
seated BP were measured based on standard measurement protocol. Determinants 
of adherence to treatment were analyzed using multiple linear regression. Out of 
5167 screened subjects, 1705 were known hypertensives. Of these, 927 (54.4%) an‐
swered the Hill‐ Bone CHBPTS and were entered into analysis. The mean age was 
59.0 ± 13.2 years, 55.6% were female and 42.2% were Malays. The mean Hill‐ Bone 
CHBPTS score was 20.4 ± 4.4 (range 14‐ 47), and 52.1% had good adherence. The 
mean systolic BP and diastolic BP were 136.4 ± 17.9 and 80.6 ± 11.6 mmHg, respec‐
tively. BP was controlled in 58.3% of those with good adherence compared to 50.2% 
in those with poor adherence (p = .014). Based on multiple linear regression analysis, 
female gender (β = −0.72, 95% confidence interval [CI] −1.30, −0.15, p = .014), older 
age (β = −0.05, 95% CI −0.07, −0.03, p < .001), and individuals with primary or lower 
educational level (β = −0.91, 95% CI −1.59, −0.23, p = .009) had better adherence to 
BP management. Interventional programs targeted at the less adherent groups are 
needed in order to improve their adherence and BP control.
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2.3  |  Sampling method and process
All eligible individuals were invited to participate in this study. 
Participants were given a questionnaire, and their body weight and 
height were measured. All BP monitors that were used have been 
validated by various international bodies (International Society of 
Hypertension, International Society of Hypertension, and British 
Society of Hypertension). Seated BP was measured three times 
based on the standard procedure of BP measurement using auto‐
mated and validated BP devices (Microlife‐ BP‐ A2‐ Basic, Omron 
JPN1, Omron HEM‐ 7121, Omron HBP‐ 1300, and Beurer BM28).18 
Following the usual clinical practice, only the first two BP measure‐
ments were used in our analysis.
2.4  |  Data collection
During the BP screening, a self‐ administered questionnaire that 
captured the sociodemographic characteristics and relevant past 
medical history were distributed by researchers. Participants also 
completed the Hill‐ Bone Compliance to high blood pressure therapy 
Scale (Hill‐ Bone CHBPTS) questionnaire. Both the validated English 
and the translated Bahasa Malaysia, the national language version of 
this scale, were used.19
2.5  |  Instruments used: The Hill- Bone Compliance 
to High Blood Pressure Therapy Scale
We chose to use the Hill‐ Bone CHBPTS as it captures not only ad‐
herence to medication but also salt reduction and keeping with ap‐
pointments.20 This Hill‐ Bone CHBPTS was developed by the John 
Hopkins University, School of Nursing in 1999.20 The questionnaire 
consists of 14 items with 3 domains (1) reducing sodium intake; (2) 
appointment keeping; and (3) medication taking, with each item rated 
on a 4‐ point Likert scale (1 = all of the time, 2 = most of the time, 
3 = some of the time, and 4 = none of the time). The score ranges 
from a minimum of 14 to 56 (maximum). The sodium domain con‐
sists of 3 items to assess dietary intake of salty foods; the appoint‐
ment keeping domain consists of 3 items to assess appointments 
for doctor visits and prescription refills, and the medication‐ taking 
domain consists of 8 items to assess medication‐ taking behavior. 
The Hill‐ Bone CHBPTS was self‐ or interviewer‐ administered in our 
study. It takes about 5 minutes for the participants to complete this 
questionnaire. The Cronbach alpha for this scale were 0.74 and 0.84 
as reported by the authors who develop this scale as the reliability 
testing of this scale was conducted at 1‐ year and 3‐ year follow‐ up.17 
The higher the mean score in Hill‐ Bone CHBPTS, the poorer the ad‐
herence. A lower compliance scale score using this tool has been 
shown to be significantly associated with higher BP readings.20 For 
this study, we defined good adherence as a score that is less than the 
group mean Hill‐ Bone CHBPTS score and poor adherence as a score 
that is equal to or greater than the group mean score.
2.6  |  Operational definitions
Ethnicity was defined as Malay, Chinese, Indian, or others. Education 
level was defined according to the respondents’ self‐ reported high‐
est attained level of education as no formal education, primary 
school, secondary school, or tertiary education (diploma/university). 
Smoking status was defined as whether the patient was a current 
smoker, non‐ smoker, or ex‐ smoker. Body Mass Index (BMI) was cal‐
culated as the weight in kg divided by the square of height in meter 
and classified according to the Asian population.21 Hypertension 
was defined as systolic BP ≥ 140 and/or diastolic BP ≥ 90 mmHg or 
on treatment for hypertension or is a known case of hypertension.22 
BP was defined as controlled if both systolic BP was <140 mmHg 
and diastolic BP was <90 mmHg or uncontrolled if either one or both 
were elevated.
2.7  |  Data analysis
Statistical Package for Social Sciences (SPSS) version 24 was used for 
the statistical analysis in this study. We used descriptive analysis, for 
example, frequencies, percentages, median, and interquartile range 
(IQR) to describe the characteristics of the participants. Independent 
t test was used to determine the association for continuous data, 
that is, Hill‐ bone CHBPTS score and BP readings and chi‐ squared 
test for categorical data, that is, percentage with controlled BP and 
adherence category. Multiple linear regression was used to identify 
the determinants of the total Hill‐ bone CHBPTS score. We ensured 
that the assumptions of multiple linear regression analysis were met 
before running the regression model.23 All variables with a p Value 
<.05 in the univariate analysis were entered into the multiple linear 
regression. The dependent variable was the total Hill‐ Bone CHBPTS 
score. The independent variables are sociodemographic factors (age, 
gender, level of education, marital status, occupation, smoking sta‐
tus, and alcohol consumption status) and clinical profiles (presence 
of diabetes, ischemic heart disease, stroke, and body mass index).
3  |  RESULTS
Out of 5167 participants screened, 1705 (33%) were hypertensive. 
Out of these, 927 (54.4%) participants answered the Hill‐ Bone 
CHBPTS questionnaire and were entered into this analysis. Table 1 
shows the sociodemographic and clinical characteristics of the par‐
ticipants with hypertension. The mean age was 59.0 ± 13.2 years. 
More than half of the participants were female (55.6%, n = 515) 
and 58.2% were housewives, students or retired. The largest eth‐
nic group was Malay (42.2%) with nearly half of them having had at 
least secondary level of education (48.3%). Majority of them were 
married (90.4%) and never consumed alcohol (92.4%). Only 11.5% of 
them were smokers. The main co‐ morbidities were diabetes (38.5%), 
followed by ischemic heart disease (7.7%) or stroke (4.5%). The mean 
BMI was 27.7 ± 5.5 kg/m2.
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The mean Hill‐ Bone CHBPTS score was 20.4 ± 4.4 (range 14‐ 
47) and the correlation between HB score and systolic BP was not 
significant (r = .032, p =.337) but the correlation between HB score 
with diastolic BP was significant (r = .163, p < .001). Based on the 
Hill‐ Bone CHBPTS, 52.1% (n = 482) had good adherence. Table 2 
shows the adherence score for the group as a whole and compares 
the adherence sub‐ scales between controlled and uncontrolled hy‐
pertension. The total score and the sub‐ scales of medication taking 
show a statistically significant difference in those with controlled 
and uncontrolled BP (p < .05), while there were no differences in the 
sub‐ scales of salt intake and appointment keeping. The mean SBP 
(systolic blood pressure) and DBP (diastolic blood pressure) of the 
hypertensive participants were 136.4 ± 17.9 and 80.6 ± 11.6 mmHg, 
respectively. Table 2 also shows the proportion of those with con‐
trolled BP was 54.4%. The control rate of diastolic BP was higher 
than systolic BP.
Table 3 shows the comparison of the mean SBP and DBP and 
control rates in those with good and poor adherence. There is sta‐
tistically significant difference between the control rates of those 
with good and poor adherence (58.3% vs 50.2%, respectively, and 
p = .014).
Table 4 shows the sociodemographic and clinical characteris‐
tics associated with total Hill‐ bone CHBPTS score using simple and 
multiple linear regression analysis. In the multiple linear regression 
analysis, it was found that female participants (β = −0.72, 95% con‐
fidence interval [CI] = −1.30, −0.15, p = .014), older aged (β = −0.05, 
95% CI = −0.07, −0.03 p < .001), and patients with background of 
primary education level and below (β = −0.91, 95% CI = −1.59, −0.23, 
p = .009) had lower Hill‐ bone CHBPTS score, indicating they had 
better adherence to BP therapy medication, salt intake and appoint‐
ment keeping.
4  |  DISCUSSION
Our study showed that individuals with hypertension who were 
older, being female and with a lower educational level were more 
adherent to BP management. Our findings are comparable to and 
consistent with other studies where patients with hypertension 
aged between 65 to 80 years had better treatment adherence com‐
pared to younger hypertensive patients (<50 years) or much older 
patients (>80 years old).24‐ 27 However, there was a study that re‐
ported younger adults had better adherence.28
Our study also showed that females have better adherence than 
males. This was in line with other studies where gender affects 
the behavior toward medication adherence.29‐ 31 Female patients 
demonstrated better and more active health‐ seeking behavior when 
empowered.32 They tend to seek substantial physical and men‐
tal health support and advice from their clinicians as compared to 
males.33 Thus, designing, implementing, and evaluating intervention 
programs to improve adherence should not be “one size fits all” but 
rather take into consideration the role gender plays in decision mak‐
ing on treatment adherence.
A surprising finding was that those with a lower educational level 
had a better adherence. This differs from two other studies that 
showed that participants with a lower educational level associated 
with a lower income and lower health literacy generally reported 
lower adherence to antihypertensive medications.34,35 This may be 
due to those with higher education who may be using alternative 
strategies like better weight control, more exercise, less smoking or 
consumption of alcohol or complementary medications to reduce 
their BP which are relevant parameters that are not captured in the 
Hill‐ Bone CHBPTS score.36 However, we also need to consider there 
may be a selection bias as there were fewer participants with higher 
education (51.0%) answering the scale versus 69.5% of those with a 
lower educational level who did so.
In our study, there was no association of adherence with a history 
of stroke. This is in contrast to a study, which showed that those with 
co‐ morbidities had better adherence.37 This could be due to the fact 
TA B L E  1  Sociodemographic and clinical characteristics of the 
study respondents (N = 927)
Variable Frequency N (%) Mean ± SD










No formal education 34 (3.7)
Primary school 185 (20.1)













1‐ 3 times /month 55 (5.9)
At least once/ week 15 (1.7)
Co‐ morbidity
Stroke 42 (4.5)
Heart attack 71 (7.7)
Diabetes 357 (38.5)
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that those with stroke had difficulty in keeping their appointment, 
which is a subscale captured in the Hill‐ bone CBPTS while other 
studies on the adherence probably have not included this domain.
This study showed that BP control rates were higher in those 
with good adherence. Our finding is consistent with other studies, 
and this emphasizes again the importance of adherence to achieve 
good BP control.20,38 Knowledge of factors associated with adher‐
ence to hypertension management will help us plan and focus more 
on those who are less adherent to achieve better BP control.
A sub‐ analysis of the determinants of DBP control was done. For 
the multiple logistic regression for determinants of DBP control are 
those with an older age, being Chinese, females, skilled worker, re‐
ceiving lower education level, underlying diabetes, and having good 
adherence (Table S1). This is consistent with the determinants of the 
good adherence. Thus, this explains why the diastolic blood pres‐
sure is better controlled among those hypertensives with a good 
adherence.
In addition, older population appeared to be one of the deter‐
minants of the good diastolic blood pressure control. This could 
be explained by the fact that the low adherence is more prevalent 
in the young population and worsens control of diastolic blood 
pressure.39
The strengths of this study are the large sample size of par‐
ticipants who closely resemble the overall socio‐ demography of 
Malaysia. This study was also conducted in a wide variety of sites, 
including rural and urban health clinics as well as screening in com‐
munity halls and universities. The main limitation was that this 
study was a cross‐ sectional study design which may limit causality. 
Another limitation was that we used an indirect measurement of ad‐
herence with self‐ reported questionnaire while the “gold standard” 
remains as the measurements of metabolites of antihypertensive 
drugs in the blood or urine.
Another limitation is the lower validity and reliability score of the 
Malay version of this Hill‐ Bone CHBPTS as reported in a previous 
local study.19 However, we have decided to use this score as it mea‐
sures more than one domain of adherence, and hence, this should 
be taken into consideration. There may also be respondent bias as 
only 54.4% of hypertensive participants answered the Hill‐ Bone 
Hill- Bone CHBPTS 
score Overall
Controlled
n = 504 (54.4%)
Not controlled
n = 422 (45.6%) p




10.3 ± 3.0 9.9 ± 2.5 10.8 ± 3.4 <.001
Salt intake 
(mean ± SD)








136.4 ± 17.9 124.8 ± 9.8 153.6 ± 12.5 <.001
DBP, mmHg 
(mean ± SD)
80.6 ± 11.6 76.4 ± 8.1 97.3 ± 7.5 <.001




— SBP 124.1 ± 9.8
DBP 74.7 ± 8.2
SBP 151.0 ± 13.9
DBP 87.6 ± 11.2
<.001
.001
Pulse rate, bpm 
(n = 899) 
(mean ± SD)
77.5 ± 12.9 75.9 ± 11.1 107.4 ± 8.3 <.001
TA B L E  2  Adherence score and 
comparison of sub‐ scales between 
controlled and not controlled 
hypertension (N = 926)
TA B L E  3  Comparison of adherence and blood pressure control (N = 926)
Measurements (n = 926) Overall mean
Hill- bone CHBPTS score category
p
Good adherence
n = 482 (52.1%)
Poor adherence





SBP, mmHg (mean ± SD) 136.4 ± 17.9 136.1 ± 17.2 136.7 ± 18.6 −0.6 1.2 .615
DBP, mmHg (mean ± SD) 80.6 ± 11.6 79.3 ± 10.5 82.1 ± 12.6 −2.9 0.8 <.001
PR, bpm (mean ± SD) 77.5 ± 12.9 76.9 ± 13.0 78.1 ± 12.8 −1.2 0.9 .116
Controlled BP (n, %) — 281 (58.3) 223 (50.2) — — .014
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CHBPTS. Nevertheless, by adjusting for cofounders in the multivari‐
ate analysis, the authors have managed to identify the true determi‐
nants of adherence using this scale.
5  |  CONCLUSION
Our study findings have shown that those older, being female and 
of a lower educational level were more adherent to hypertension 
management. Furthermore, as adherence to reduction in salt intake, 
medication taking and appointment keeping have been associated 
with better BP control among patients with hypertension, it is es‐
sential for clinicians to engage and educate the patients about the 
importance of adherence through identifying the correlated factors 
of non‐ adherence in improving BP control.
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Age −0.05 (−0.07, 
−0.03)




Male 22.0 ± 4.4 −0.61 (−1.17, 
−0.04)
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−0.15)
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Marital Status (married)







Employed 20.8 ± 4.4 0.69 (0.12,1.26) .017 — 




19.7 ± 3.6 −0.94 (−1.60, 
−0.28)














Yes 21.1 ± 4.4 −0.71 (−1.61, 
0.18)
.118 — 
No 20.3 ± 4.4
Alcohol consumption
Yes 20.1 ± 4.0 −0.50 (−1.32, 
0.33)
.235 — 
No 20.4 ± 4.4
Diabetes status
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Heart attack
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